A medical pump includes a cuboid pump housing and a front lid that is pivotably hinged to the pump housing. The front lid includes a display, in particular a touch display, and/or operating elements. The front lid is attached to the pump housing with at least one first hinge element and at least one second hinge element. The at least one first hinge element and/or the at least one second hinge element includes or forms at least one electrical connection between the pump housing and the front lid for electrical linking and exchange of data.

Drug delivery systems and methods are provided for monitoring and/or tracking exposure of a drug to one or more conditions that can affect performance of the drug.

A prepackaged injectable pharmaceutical composition includes a sealed outer package made of a material having a low oxygen transmission rate and an inner package disposed within the sealed outer package. The inner package is configured to provide an indication that the inner package has been opened after being closed. A prefilled syringe is disposed within the inner package. The syringe includes a barrel comprising a polymeric material and a dose of the injectable pharmaceutical composition.

An inhaler includes a mouthpiece cover, a pressure sensor, a first indicator and a second indicator. The first indicator may be configured to indicate based on a state of the cover, and the second indicator may be configured to indicate based on an output of the pressure sensor. For example, when the mouthpiece cover opens, the first indicator may illuminate and a dose of medication may be transferred from a reservoir to a dosing cup. The second indicator may illuminate if an amount of inhaled medication reaches a predetermined threshold for successful inhalation.

A disposable electronically controlled infusion pump system includes at least one disposable infusion container and at least one disposable electronically controlled medication pumping system. The at least one disposable infusion container is configured to contain infusion fluid. The at least one disposable electronically controlled medication pumping system is fluidly connected to the at least one disposable infusion container. The at least one disposable electronically controlled medication pumping system includes an infusion channel, a disposable electronically controlled micropump, and valves, but may further include a microprocessor, a memory, a battery or a power receiver configured to wirelessly receive power, a wireless communication device, and other components. The memory is in electronic communication with the microprocessor. The wireless communication device is configured to receive a wireless signal which wirelessly controls the at least one disposable electronically controlled medication pumping system. The disposable electronically controlled micropump is configured to pump the infusion fluid through the infusion channel. The valves are connected to the infusion channel.

A hookah device (202) which attaches to a hookah (246). The hookah device (202) comprises a plurality of ultrasonic mist generator devices (201) for generating a mist for inhalation by a user. The hookah device (202) comprises a driver device (202) which controls the mist generator devices (201) to maximize the efficiency of mist generation by the mist generator devices (201) and optimize mist output from the hookah device (202).

The invention relates to a communications device for non-electric communication between fluidically interconnected devices, the communications device being designed to be mounted in a position in a fluidic overall system formed by the fluidically interconnected devices and to receive and/or emit non-electric signals, in particular in the form of pressure or sound signals, the non-electric signals being transmitted via a line that fluidically interconnects the devices. The invention further relates to a method for non-electric communication between fluidically interconnected devices, the non-electric communication taking place preferably by means of pressure and/or sound signals via at least one line that fluidically interconnects the devices.

A fluid sensing apparatus and method for detecting pressure and the presence of bubbles within a fluid tube. The fluid sensor comprises a housing configured to receive a portion of the tube and to house the pressure sensor and the ultrasonic transmitter. The pressure sensor is positioned adjacent the tube and is configured to receive a pressure sensor signal, which correlates to a detected pressure differential within the tube. A controller transmits a drive signal to the ultrasonic transmitter, which emits ultrasonic waves through a portion of the tube and to the pressure sensor. The pressure sensor receives both the ultrasonic waves and a pressure sensor signal, and subsequently transmits an output signal to the controller. In the presence of a pressure differential or a bubble within the tube, the output signal will exhibit a DC shift or a distortion of its signal characteristics, respectively.

A treatment system (100) for treating a patient comprises a medical device (10) and a portable authentication device (20), wherein the medical device (10) is adapted to output an acoustic signal when a wireless communication connection between the medical device (10) and the portable authentication device (20) is successfully established, the portable authentication device (20) is adapted to receive the acoustic signal, to generate, based on the received acoustic signal, a signal containing a signal corresponding to the received acoustic signal, and to wirelessly transmit the generated signal to the medical device (10), and the medical device (10) is adapted to determine whether or not the portable authentication device (20) is located at a position where acoustic communication between the medical device (10) and the portable authentication device (20) is possible, depending on whether or not it receives the signal containing the signal corresponding to the acoustic signal received by the portable authentication device (20).

A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.